If the road to hell is paved with good intentions, Washington has turned federal prescription drug policy into an eight-lane ...
The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...
The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...
A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.
Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...
The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...
The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.
Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% ...
On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...
Halo340B today called on Federally Qualified Health Centers and other 340B covered entities to take a more strategic and mission-driven approach to understanding their 340B gross-to-net performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results